J-TEC obtains permission to manufacture and sell for surgery “Jack”, a 3D-cartilage preparation of autologous chondrocyte-containing atelocollagen gel
J-TEC press release, July 30, 2012
Nitto Denko and Dainippon Sumitomo Pharma start phase II clinical trial of Ronasen (R), a percutaneous tape pharmaceutical preparation for schizophrenia treatment
Dainippon Sumitomo Pharma press release, July 27, 2012
Takeda starts pan-Asian phase III study for AMG706 (2-modesanib-phosphate), a lung cancer drug, in Japan, Hong Kong, South Korea, and Taiwan
Takeda press release, July 26, 2012
Sumitomo and Sumitomo South Korea to finance 25 % of South Korean cosmetics venture Biogenics, specialized in nano-galenics for skin penetration
Sumitomo press release, July 25, 2012
Rohto Pharmaceutical develops low-molecular weight chondroitin sulfate easily absorbed from intestine, functional material for edema prevention in arthritis (animal model)
Rohto Pharmaceutical develops low-molecular weight chondroitin sulfate easily absorbed from intestine, functional material for edema prevention in arthritis (animal model)
Sapporo Breweries and AIST: Lactobacillus lactis SBL88 ingestion improves insomnia in stressed mouse model
AIST press release, July 24, 2012
Nisshin Pharma introduces “Blue soybean EX powder” as functional food material which preserves learning ability on ageing
Nisshin Pharma press release, July 24, 2012
Nippon Suisan releases IMAK-S, a DHA- and EPA-containing drink with FOSHU-supported health claims to lower neutral fat in blood, storage-stable at room temperature.
Nippon Suisan press release, July 23, 2012